Status:
COMPLETED
Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence
Lead Sponsor:
Intuitive Surgical
Conditions:
Lung Cancer
Pulmonary Nodule, Solitary
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.
Eligibility Criteria
Inclusion
- Age of 18 years or older
- Undergoing a lung biopsy procedure with Ion System
- Have peripheral pulmonary lesion (5th bronchial generation or higher)
- Willingness to participate as demonstrated by signing the informed consent
Exclusion
- Unable to provide informed consent
- Presence of bilateral nodules intended to be biopsied during procedure
- The presence of medical conditions contraindicating general anesthesia or bronchoscopic biopsy
- Vulnerable population (e.g., prisoners, mentally disabled)
Key Trial Info
Start Date :
December 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04735341
Start Date
December 9 2020
End Date
June 30 2022
Last Update
August 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FirstHealth of the Carolinas Moore Regional Hospital
Pinehurst, North Carolina, United States, 28374